I was in Seattle for the week at the Society for Biomaterials 2019 conference. Excited to have data from three projects in four sessions at SFB 2019. Thanks to CTSI-PDT (#CTSI), ACS-IRG(#americancersociety), NDnano, AD&T and HCRI for their crucial support for these projects. 1. Rapid-Fire oral Presentation on Wednesday on April 3, 2019, from 4:05 …
Tag Archive: #AD&T
Recent Posts
- Invited Talk at the Innovation Sciences Seminar Series hosted at Rosalind Franklin University of Medicine and Science February 12, 2026
- Our Lab at Notre Dame Receives Notice of Allowance for Novel Nanoparticle Immunotherapy Technology January 19, 2026
- 2025 in Review: Innovation, Funding, and Student Success December 9, 2025
- Precision Chemotherapy: Externally Controlled Nanocarriers for Aggressive Cancers December 6, 2025
- Congratulations to Our Newest PhD Candidate, Aurelie Brownsberger! 🎓 November 13, 2025
Archives
Categories
NIH Funding Opportunities
- Notice of Change: Expiration of PAR-25-090 -- NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional) February 18, 2026Notice NOT-DK-26-102 from the NIH Guide for Grants and Contracts
- Notice of Early Expiration of PAR-25-099, "Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)" February 18, 2026Notice NOT-AI-26-006 from the NIH Guide for Grants and Contracts
- Notice of Early Expiration of PAR-25-330, "Role of Defective Proviruses in HIV Persistence (R01 Clinical Trial Not Allowed)" February 18, 2026Notice NOT-AI-26-007 from the NIH Guide for Grants and Contracts
- Notice of Early Expiration of PAR-25-300, "Targeting Cell Surface HIV Envelope for Cell Elimination (R01 Clinical Trial Not Allowed)" February 18, 2026Notice NOT-AI-26-008 from the NIH Guide for Grants and Contracts
- Notice of Early Expiration of PAR-25-316 "Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R21 Clinical Trial Not Allowed)" February 18, 2026Notice NOT-AI-26-009 from the NIH Guide for Grants and Contracts
- Notice of Early Expiration of PAR-25-315, "Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R01 Clinical Trial Not Allowed)" February 18, 2026Notice NOT-AI-26-010 from the NIH Guide for Grants and Contracts
- NIA Intervention Testing Program (ITP) Announces Annual Call for Compounds to Test for Lifespan Extension in Mice February 18, 2026Notice NOT-AG-25-014 from the NIH Guide for Grants and Contracts
- Reminder of Requirement for Certification of IRB Approval February 18, 2026Notice NOT-OD-26-043 from the NIH Guide for Grants and Contracts

Recent Comments